Wednesday, October 31, 2018

US FDA News: FDA authorizes first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism

FDA authorizes first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism
Read more: FDA authorizes first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism